Myelodysplastic syndrome/myeloproliferative neoplasm overlap syndromes: a focused review.
Patnaik MM, Lasho T.
Hematology Am Soc Hematol Educ Program. 2020 Dec 4;2020(1):460-464. doi: 10.1182/hematology.2020000163.
Genomics of myelodysplastic syndrome/myeloproliferative neoplasm overlap syndromes.
Patnaik MM, Lasho TL.
Hematology Am Soc Hematol Educ Program. 2020 Dec 4;2020(1):450-459. doi: 10.1182/hematology.2020000130.
Autoimmune manifestations associated with myelodysplastic syndromes.
Grignano E, Jachiet V, Fenaux P, Ades L, Fain O, Mekinian A.
Ann Hematol. 2018 Nov;97(11):2015-2023. doi: 10.1007/s00277-018-3472-9. Epub 2018 Aug 8.
The International Consensus Classification of myelodysplastic syndromes and related entities.
Hasserjian RP, Orazi A, Orfao A, Rozman M, Wang SA.
Virchows Arch. 2023 Jan;482(1):39-51. doi: 10.1007/s00428-022-03417-1.
Genomic landscape of neutrophilic leukemias of ambiguous diagnosis.
Zhang H, Wilmot B, Bottomly D, Dao KT, Stevens E, Eide CA, Khanna V, Rofelty A, Savage S, Reister Schultz A, Long N, White L, Carlos A, Henson R, Lin C, Searles R, Collins RH, DeAngelo DJ, Deininger MW, Dunn T, Hein T, Luskin MR, Medeiros BC, Oh ST, Pollyea DA, Steensma DP, Stone RM, Druker BJ, McWeeney SK, Maxson JE, Gotlib JR, Tyner JW.
Blood. 2019 Sep 12;134(11):867-879. doi: 10.1182/blood.2019000611. Epub 2019 Jul 31.
Myelodysplastic/myeloproliferative neoplasm, unclassifiable (MDS/MPN-U): More than just a "catch-all" term?
Shallis RM, Zeidan AM.
Best Pract Res Clin Haematol. 2020 Jun;33(2):101132. doi: 10.1016/j.beha.2019.101132. Epub 2019 Dec 6.
Myelodysplastic/myeloproliferative neoplasms.
Cazzola M, Malcovati L, Invernizzi R.
Hematology Am Soc Hematol Educ Program. 2011;2011:264-72. doi: 10.1182/asheducation-2011.1.264.
[Myelodysplastic syndrome classification].
Ghariani I, Braham N, Hassine M, Kortas M.
Ann Biol Clin (Paris). 2013 Mar-Apr;71(2):139-44. doi: 10.1684/abc.2013.0804.
Myelodysplastic/myeloproliferative neoplasms.
Hyjek E, Vardiman JW.
Semin Diagn Pathol. 2011 Nov;28(4):283-97. doi: 10.1053/j.semdp.2011.07.002.
Clinical outcome of patients diagnosed with myelodysplastic syndrome-unclassifiable (MDS-U): single center experience.
Baidoun F, Chen D, Patnaik M, Gangat N, Begna K, Elliott M, Hogan W, Litzow M, Al-Kali A.
Leuk Lymphoma. 2019 Oct;60(10):2483-2487. doi: 10.1080/10428194.2019.1581930. Epub 2019 Mar 7.
